Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Current Taxes: 2012-2025

Historic Current Taxes for Ascendis Pharma A (ASND) over the last 10 years, with Sep 2025 value amounting to $1.9 million.

  • Ascendis Pharma A's Current Taxes rose 68.69% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 68.69%. This contributed to the annual value of $1.3 million for FY2024, which is 46.53% down from last year.
  • Latest data reveals that Ascendis Pharma A reported Current Taxes of $1.9 million as of Q3 2025, which was up 133.86% from $804,823 recorded in Q2 2025.
  • Ascendis Pharma A's Current Taxes' 5-year high stood at $7.4 million during Q1 2023, with a 5-year trough of $96,035 in Q2 2022.
  • For the 3-year period, Ascendis Pharma A's Current Taxes averaged around $3.2 million, with its median value being $1.9 million (2025).
  • Per our database at Business Quant, Ascendis Pharma A's Current Taxes soared by 6,445.90% in 2023 and then slumped by 84.18% in 2024.
  • Ascendis Pharma A's Current Taxes (Quarterly) stood at $226,506 in 2021, then spiked by 2,372.85% to $5.6 million in 2022, then plummeted by 55.84% to $2.5 million in 2023, then crashed by 47.21% to $1.3 million in 2024, then skyrocketed by 68.69% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $804,823 for Q2 2025, and $1.7 million during Q1 2025.